serw-MX  [xml]  
 


    
 DeCS Categories

D02 Organic Chemicals .
D02.065 Amides .
D02.065.064 Acetamides .
D02.065.064.650 Piracetam .
D02.241 Carboxylic Acids .
D02.241.081 Acids, Acyclic .
D02.241.081.018 Acetates .
D02.241.081.018.110 Acetamides .
D02.241.081.018.110.650 Piracetam .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.773 Pyrrolidines .
D03.383.773.812 Pyrrolidinones .
D03.383.773.812.555 Piracetam .
D08 Enzymes and Coenzymes .
D08.811 Enzymes .
D08.811.277 Hydrolases .
D08.811.277.656 Peptide Hydrolases .
D08.811.277.656.300 Endopeptidases .
D08.811.277.656.300.480 Metalloendopeptidases .
D08.811.277.656.300.480.153 Botulinum Toxins .
D08.811.277.656.300.480.153.100 Botulinum Toxins, Type A .
D08.811.277.656.675 Metalloproteases .
D08.811.277.656.675.374 Metalloendopeptidases .
D08.811.277.656.675.374.153 Botulinum Toxins .
D08.811.277.656.675.374.153.100 Botulinum Toxins, Type A .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.097 Bacterial Proteins .
D12.776.097.156 Botulinum Toxins .
D12.776.097.156.100 Botulinum Toxins, Type A .
D23 Biological Factors .
D23.946 Toxins, Biological .
D23.946.123 Bacterial Toxins .
D23.946.123.179 Botulinum Toxins .
D23.946.123.179.050 Botulinum Toxins, Type A .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.706 Protective Agents .
D27.505.696.706.548 Neuroprotective Agents .
D27.505.954 Therapeutic Uses .
D27.505.954.427 Central Nervous System Agents .
D27.505.954.427.575 Neuroprotective Agents .
D27.505.954.427.637 Nootropic Agents .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Piracetam .
2-Pyrrolidone-N-Acetamide .
Avigilen .
Axonyl .
Cerebroforte .
Cerepar N .
Ciclofalina .
Cuxabrain .
Dinagen .
Gabacet .
Geram .
Memo-Puren .
Nootrop .
Nootropil .
Nootropyl .
Normabraïn .
Piracebral .
Piracetam AbZ .
Piracetam-RPh .
Piracetrop .
Pirazetam .
Pyracetam .
Pyramem .
Sinapsan .
UCB-6215 .
Memo Puren .
Piracetam RPh .
UCB 6215 .
UCB6215 .
A compound suggested to be both a nootropic and a neuroprotective agent. .
1.00
212987
 
Nootropic Agents .
Nootropic Drugs .
Nootropics .
Agents, Nootropic .
Drugs, Nootropic .
Enhancers, Cognitive .
Cognitive Enhancers .
Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. While no potent nootropic drugs have yet been accepted for general use, several are being actively investigated. .
0.50
264249
 
Neuroprotective Agents .
Neuroprotectants .
Neuroprotective Drugs .
Neuroprotective Effect .
Neuroprotective Effects .
Agents, Neuroprotective .
Drugs, Neuroprotective .
Effect, Neuroprotective .
Effects, Neuroprotective .
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. .
0.40
12229079
 
Botulinum Toxins, Type A .
Botulinum A Toxin .
Botulinum Neurotoxin A .
Clostridium Botulinum Toxin Type A .
Clostridium botulinum A Toxin .
Meditoxin .
Neuronox .
Oculinum .
Neurotoxin A, Botulinum .
Toxin, Botulinum A .
Botulinum Toxin Type A .
A serotype of botulinum toxins that has specificity for cleavage of SYNAPTOSOMAL-ASSOCIATED PROTEIN 25. .
0.38
2117696